The VPAC2 agonist peptide histidine isoleucine (PHI) up-regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1G93A) by inhibiting caspase-3 mediated inactivation of GLT-1a (Q45170678)
Jump to navigation
Jump to search
scientific article published on 5 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The VPAC2 agonist peptide histidine isoleucine (PHI) up-regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1G93A) by inhibiting caspase-3 mediated inactivation of GLT-1a |
scientific article published on 5 July 2011 |
Statements
1 reference
The VPAC2 agonist peptide histidine isoleucine (PHI) up-regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1G93A) by inhibiting caspase-3 mediated inactivation of GLT-1a (English)
1 reference
Stéphanie Goursaud
1 reference
Marylène C Focant
1 reference
Julie V Berger
1 reference
Yannick Nizet
1 reference
Jean-Marie Maloteaux
1 reference
Emmanuel Hermans
1 reference
5 July 2011
1 reference
1 reference
Identifiers
1 reference